» Articles » PMID: 28795510

CNGB3 Mutation Spectrum Including Copy Number Variations in 552 Achromatopsia Patients

Overview
Journal Hum Mutat
Specialty Genetics
Date 2017 Aug 11
PMID 28795510
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Achromatopsia is a rare autosomal recessive cone disorder characterized by color vision defects, photophobia, nystagmus, and severely reduced visual acuity. The disease is caused by mutations in genes encoding crucial components of the cone phototransduction cascade (CNGA3, CNGB3, GNAT2, PDE6C, and PDE6H) or in ATF6, involved in the unfolded protein response. CNGB3 encoding the beta subunit of the cyclic nucleotide-gated ion channel in cone photoreceptors is the major achromatopsia gene. Here, we present a comprehensive spectrum of CNGB3 mutations and their prevalence in a cohort of 1074 independent families clinically diagnosed with achromatopsia. Of these, 485 (45.2%) carried mutations in CNGB3. We identified a total of 98 different potentially disease-causing CNGB3 variants, 58 of which are novel. About 10% of patients with CNGB3 mutations only harbored a single heterozygous variant. Therefore, we performed quantitative real-time PCR in 43 of such single heterozygotes in search of the missing allele, followed by microarray-based comparative genomic hybridization and breakpoint mapping. We discovered nine different heterozygous copy number variations encompassing one to 10 consecutive exons in 16 unrelated patients. Moreover, one additional patient with a homozygous CNGB3 deletion encompassing exons 4-18 was identified, highlighting the importance of CNV analysis for this gene.

Citing Articles

Gene Therapy for Achromatopsia.

Baxter M, Borchert G Int J Mol Sci. 2024; 25(17).

PMID: 39273686 PMC: 11396370. DOI: 10.3390/ijms25179739.


Clinical characterizations and molecular genetic study of two co-segregating variants in PDZD7 and PDE6C genes leading simultaneously to non-syndromic hearing loss and achromatopsia.

Nouri Z, Sarmadi A, Narrei S, Kianersi H, Kianersi F, Tabatabaiefar M BMC Med Genomics. 2024; 17(1):173.

PMID: 38956522 PMC: 11218353. DOI: 10.1186/s12920-024-01942-3.


Molecular Mechanisms Governing Sight Loss in Inherited Cone Disorders.

Brotherton C, Megaw R Genes (Basel). 2024; 15(6).

PMID: 38927662 PMC: 11202562. DOI: 10.3390/genes15060727.


Spectrum of variants associated with inherited retinal dystrophies in Northeast Mexico.

Villafuerte-de la Cruz R, Garza-Garza L, Garza-Leon M, Rodriguez-De la Torre C, Parra-Bernal C, Vazquez-Camas I BMC Ophthalmol. 2024; 24(1):60.

PMID: 38347443 PMC: 10860328. DOI: 10.1186/s12886-023-03276-7.


Dyschromatopsia: a comprehensive analysis of mechanisms and cutting-edge treatments for color vision deficiency.

Yang Z, Yan L, Zhang W, Qi J, An W, Yao K Front Neurosci. 2024; 18:1265630.

PMID: 38298913 PMC: 10828017. DOI: 10.3389/fnins.2024.1265630.